Gene · 284656
Papers352
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 352
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Modulating pseudokinase conformation from the ATP-binding site. | Structure | 2026 | 42759518 | PubTator, text mining | PubMed |
| N-Gene and T-Gene deregulation networks: a data-driven causal framework for the analysis of gene interventions in cancer. | Front Syst Biol | 2026 | 42465838 | PubTator, text mining | PubMed |
| The multifaceted roles of receptor tyrosine pseudokinases in cellular signalling. | Biochem Soc Trans | 2026 | 42267535 | PubTator, text mining | PubMed |
| Eph receptors in pancreatic cancer: Biological roles and clinical implications. | Crit Rev Oncol Hematol | 2026 | 41903913 | PubTator, text mining | PubMed |
| Distinct molecular pathways leading to dosage-dependent temozolomide resistance in GBM stem cells. | Cancer Cell Int | 2026 | 41736030 | PubTator, text mining | PubMed |
| FOXM1 regulates platelet-induced anoikis resistance in pancreatic cancer cells. | Cell Commun Signal | 2026 | 41535944 | PubTator, text mining | PubMed |
| Targeting ephrin receptor A10 with antibody-drug conjugates for breast cancer. | Cancer Lett | 2026 | 41423054 | PubTator, text mining | PubMed |
| The N6-methyladenosine Modified EphA10 Promotes Prostate Cancer Progression by Activating the ERK/AKT Pathway. | Biochem Genet | 2026 | 41296142 | PubTator, text mining | PubMed |
| Elevated Expression of EphA10 in Gastric Cancer Tissues: A Potential Biomarker for Tumor Metastasis and Poor Survival. | Tohoku J Exp Med | 2026 | 40603106 | PubTator, text mining | PubMed |
| A new serological autoantibody signature associated with multiple sclerosis. | Neurobiol Dis | 2025 | 41038542 | PubTator, text mining | PubMed |
| Development and validation of a kinase-related gene signature as a novel diagnostic and prognostic model for prostate cancer. | Biochim Biophys Acta Mol Basis Dis | 2025 | 39965532 | PubTator, text mining | PubMed |
| The mechanism of all-trans retinoic acid-induced cleft palate may be related to the novel ENSMUST00000159153-miR-137-5p-Wnt7a and ENSMUST000000236086-miR-34b-3p-EphA10/TRPM2 ceRNA crosstalk. | Environ Toxicol Pharmacol | 2025 | 39710122 | PubTator, text mining | PubMed |
| Comprehensive analysis of Epha10 as a predictor of clinical prognosis and immune checkpoint therapy efficacy in non-small cell lung cancer. | Sci Rep | 2024 | 39179608 | PubTator, text mining | PubMed |
| Prognostic microRNAs as biomarkers for prostate cancer. | J Cancer Res Ther | 2024 | 38554337 | PubTator, text mining | PubMed |
| Location, location, location: Protein kinase nanoclustering for optimised signalling output. | Elife | 2024 | 38206309 | PubTator, text mining | PubMed |
| Recurring EPHB1 mutations in human cancers alter receptor signalling and compartmentalisation of colorectal cancer cells. | Cell Commun Signal | 2023 | 38102712 | PubTator, text mining | PubMed |
| Receptor tyrosine kinases: biological functions and anticancer targeted therapy. | MedComm (2020) | 2023 | 38077251 | PubTator, text mining | PubMed |
| Clinicopathological and prognostic significance of Ephrin A3 in bladder urothelial carcinoma. | Oncol Lett | 2023 | 37927410 | PubTator, text mining | PubMed |
| Remodeling the tumor immune microenvironment via siRNA therapy for precision cancer treatment. | Asian J Pharm Sci | 2023 | 37920650 | PubTator, text mining | PubMed |
| Molecular Determinants of EphA2 and EphB2 Antagonism Enable the Design of Ligands with Improved Selectivity. | J Chem Inf Model | 2023 | 37910792 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/284656/papers